Last reviewed · How we verify
NCT04499846: STADIA
Educational Intervention Targeting Statin Therapy and Compliance in Diabetic Patients
trial testing Therapeutic education in Type II Diabetes in 96 participants. Completed in 7 May 2021.
7 May 2021
Quick facts
| Lead sponsor | Lille Catholic University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 96 |
| Start date | 11 June 2020 |
| Primary completion | 7 May 2021 |
| Estimated completion | 7 May 2021 |
| Sites | 1 location across France |
Drugs / interventions tested
- Therapeutic education
Conditions studied
- Type II Diabetes — all drugs for Type II Diabetes →
Sponsor
Lille Catholic University
Who can join
18 and older, any sex, with Type II Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the study is to measure changes in compliance to statin therapy in patients with type 2 diabetes after an educational intervention. This intervention is part of the therapeutic education of the diabetic patient, carried out throughout the follow-up of his/her diabetes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04499846
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Therapeutic education
Trials testing the same drug.
- NCT07469540 — Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arth · NA · recruiting
- NCT06353568 — Effect of Photobiomodulation as a Preventive Treatment for Diabetic Foot · NA · recruiting
- NCT05919953 — Feasibility, Acceptability, and Usability of a Tele-rehabilitation Combining Immersive Virtual Reality Exercises and The · NA · completed
- NCT05676593 — Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients · NA · unknown
- NCT05159843 — Effects of Nursing Diabetes Self-management Education · NA · unknown
Other recruiting trials for Type II Diabetes
Currently open trials in the same condition.
- NCT06049420 — Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients · NA · recruiting
- NCT06385626 — The Effects of Raspberry Leaf Tea on Blood Glucose Control · NA · recruiting
- NCT05074732 — Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study. · recruiting
Other Lille Catholic University trials
Trials by the same sponsor.
- NCT06634225 — Use of Inertial Units in Patient With Multiple Sclerosis (IMUSEP) · completed
- NCT06116929 — Hodgkin's Disease and Chemotherapy Before 40 Years · NA · not yet recruiting
- NCT05208099 — Study of the Immunomodulation in the Hidradenitis Suppurativa and Evaluation of a New Therapeutic Strategy · not yet recruiting
- NCT06318923 — Social and Moral Cognition in Multiple Sclerosis · NA · unknown
- NCT06083415 — Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04499846 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lille Catholic University
- Last refreshed: 13 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04499846.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing